Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Kōichi Nakao, Kenji Andò et al.|JAMA|2019Cited by 830
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresMasahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji et al.|Journal of the American Heart Association|2018Cited by 196
Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary StentsTakeshi Kimura, Ken Kozuma, Takeshi Morimoto et al.|Circulation|2012Cited by 157
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi et al.|Circulation Cardiovascular Interventions|2019Cited by 135
Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal StentMasahiro Natsuaki, Takeshi Kimura, Takeshi Morimoto et al.|Circulation Cardiovascular Interventions|2014Cited by 77